Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon therapy in myelomatosis

H Mellstedt, A Ahre, M Björkholm

    Lancet (London, England)
    |February 3, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Human leucocyte interferon showed promise in treating myelomatosis. Two patients achieved complete remission, and two had partial remission, with no disease progression observed.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cytogenetic evolution patterns in non-Hodgkin's lymphoma.

    Blood·1995
    Same author

    Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors.

    The journals of gerontology. Series A, Biological sciences and medical sciences·1995
    Same author

    [Lessons learned from the Råneälv accident. Role distribution important during crisis intervention].

    Lakartidningen·1995
    Same author

    Continuity and discontinuity in the anti-V3 IgG response of human immunodeficiency virus type 1-infected persons in a cross-sectional and longitudinal study using synthetic peptides.

    The Journal of infectious diseases·1995
    Same author

    Adenosine A2A receptors stimulate acetylcholine release from nerve terminals of the rat hippocampus.

    Neuroscience letters·1995
    Same author

    [Private health insurance can improve health care].

    Lakartidningen·1995

    Area of Science:

    • Oncology
    • Immunology
    • Hematology

    Background:

    • Multiple myeloma is a cancer of plasma cells.
    • Current treatments have limitations and side effects.
    • Interferon-alpha has shown some activity in hematologic malignancies.